Delivery Order SPE2DB22D1017-SPE2DB25FYRBS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,398.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $1,296.00 with a firm fixed price arrangement. This competitively awarded, non-set-aside contract has an ultimate completion date of June 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,391.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award was issued on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,200.33 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packets. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,296.00. The contract was competitively awarded without set-aside provisions and is classified as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will be based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,802.75 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packets. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a delivery order valued at $1,938.18 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRBSDelivery Order
The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen Drug Corp's DLA Troop Support Medical prime contract (SPE2DX), valued at $999,999,999 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. This testosterone product delivery supports the Defense Health Agency and other government healthcare systems requiring hormone treatments as part of their medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |